CHM
Click for more information
0.00% 1.4¢ chimeric therapeutics limited

Ann: Dr Rebecca McQualter appointed COO, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. pinch2020
    780 Posts.
    lightbulb Created with Sketch. 530
    clock Created with Sketch.
    08/05/24
    08:08
    Post #: 73715821
    Looks like our new COO is in the states learning the ropes this week.

    It won't surprise me at all if we get word of the initiation of CHM 2101 any day now. On the clinical trial website, the trials original estimated start date was May. That was changed early this year to mid year. No coincidence it aligns with Jens departure.

    From LinkedIn.


    Eliot Bourk• 3rd+Chief Business Officer at Chimeric Therapeutics

    5d
    Congratulations and welcome Rebecca!


    Rebecca McQualter(She/Her)AuthorCOO Chimeric Therapeutics ASX: CHM

    4d
    Eliot Bourk thank you! Can’t wait to meet you in person next week!
    CHM Price at posting: 2.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.
NEWS Waroona Project financing strategy aims for non-dilutive funding solutions - discover how this approach will support its Stage One development
right-arrow Created with Sketch.
NEWS Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
right-arrow Created with Sketch.
NEWS Significant shallow gold intersections at Tambourah King reveal potential extensions to the lode gold system, with promising RC drill results and more assays pending
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
NEWS High-grade drill results confirm extension at Paddy’s Lodes—reinforcing significant discovery and growth potential at Youanmi Gold Project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $12.67M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.